Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of apigenin on preparation of medicine for treating pneumonia

A technology of apigenin and pneumonia, applied in the field of medicine, can solve problems such as treatment failure

Active Publication Date: 2013-01-16
SHANDONG JINZHUJI PHARM CO LTD +1
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Current drugs for the treatment of Staphylococcus aureus pneumonia usually use oxacillin and cloxacillin, but due to the emergence of MRSA, treatment failure often occurs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of apigenin on preparation of medicine for treating pneumonia
  • Application of apigenin on preparation of medicine for treating pneumonia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] 1. Hemolysis test

[0008] Different concentrations of apigenin were co-cultured with Staphylococcus aureus until late logarithmic growth, and the bacterial supernatant was collected by high-speed centrifugation. Take 100 μL of bacterial supernatant, 875 μL of PBS and 25 μL of defibrinated rabbit red blood cells, mix evenly, incubate at 37°C for 15 min, and observe the changes in the hemolytic activity of the bacterial supernatant treated with different concentrations of apigenin. The hemolysis ratio was calculated using the bacterial supernatant without apigenin as a control.

[0009] Table 1. The effect of apigenin on the hemolytic activity of Staphylococcus aureus α-hemolysin

[0010] Apigenin (μg / ml)

Hemolysis ratio (%)

0

100

1

78.14

2

52.24

4

11.06

8

3.11

[0011] 2. Protection test of human lung epithelial cells (A549) injury

[0012] Staphylococcu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of apigenin on preparation of a medicine for treating pneumonia. A therapeutical effect of the apigenin on staphylococcus aureus infection is proved by a rabbit red blood cell haemolysis test, a protection test of human pulmonary epithelial cells (A549) damage and a mice staphylococcus aureus pneumonia model. Compared with an antibiotic therapy, a therapy applying the apigenin has the characteristics of no drug tolerance and high cure rate.

Description

technical field [0001] The invention relates to the application of apigenin in the preparation of medicines for treating pneumonia, belonging to the field of medicine. 1. Background Technology [0002] Apigenin (Apigenin) is a flavonoid compound extracted and isolated from plants such as Umbelliferae celery. Both diplococcus and meningococcus have inhibitory effect, and the minimum inhibitory concentration (MIC) is between 64-256 μg / ml. But so far, there are no reports of apigenin being used in the treatment of bacterial pneumonia at home and abroad. [0003] Bacterial pneumonia is a disease caused by infections such as Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, Legionella, etc. The mortality rate of this disease is extremely high in children, the elderly and immunocompromised patients. In recent years, the extensive use of antibiotics has led to an increase in the rate of bacterial resistance, making the treatment of b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/352A61P11/00A61P31/04A61P31/10
Inventor 邓旭明董靖邱家章谭为
Owner SHANDONG JINZHUJI PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com